Prothena Corporation plc provided earnings guidance for the year 2022. The estimated full year 2022 net cash used in operating and investing activities is primarily driven by an estimated net loss of $154 to $170 million, which includes an estimated $32 million of non-cash share-based compensation expense.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.34 USD | -3.00% | -6.93% | -41.28% |
May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.28% | 1.15B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Corporation plc Provides Earnings Guidance for the Year 2022